NeuroNova
Latest round
- Series D
Last raised
- Mar 2010
Total raised
- $30M
Investors
- 6
About NeuroNova
NeuroNova AG is a biopharmaceutical company focusing on the development and commercialisation of novel drugs against depression, bipolar affective disorders, and anxiety.
Who invested in NeuroNova
6 investors across 4 rounds
See all investors in NeuroNova
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NeuroNova
Who invested in NeuroNova?
NeuroNova has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeuroNova raised?
NeuroNova has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did NeuroNova last raise money?
NeuroNova's most recent round on record is a Series D, in Mar 2010.
What does NeuroNova do?
NeuroNova AG is a biopharmaceutical company focusing on the development and commercialisation of novel drugs against depression, bipolar affective disorders, and anxiety.
Where is NeuroNova headquartered?
NeuroNova is headquartered in Munich, Germany.
Which VCs invest in companies like NeuroNova?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at NeuroNova's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like NeuroNova? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.